Dana dhuwit perusahaan TherapeuticsMD (TXMD)

Stable sales of women's health medications provide TherapeuticsMD, Inc. (TXMD) with predictable revenue. Current cash reserves demonstrate liquidity volatility, where the current parameter equals 0.01. However, geopolitics and supply chain complexities from Asia create external risks. Meanwhile, the transition to licensing has enabled the company to optimize its workforce, reducing personnel costs to a minimum.
Rincian metrik komprehensif lan analitis TherapeuticsMD, Inc. (TXMD)

This metric measures the volume of immediately available liquid funds, allowing for an assessment of the capital burn rate and the risk of cash flow gaps. By analyzing the cash liquidity chart, an investor determines the balance between financial stability and asset utilization efficiency, which for the TherapeuticsMD, Inc. (TXMD) royalty holding confirms management's ability to minimize costs while managing the patent portfolio.